Benzinga | Feb 10, 2021 06:09AM EST

United Therapeutics Announces Commercial Launch Of The Remunity Pump For Remodulin

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ:UTHR) announced today that it has launched commercial sales of the innovative Remunity(r) Pump for Remodulin(r) for patients with pulmonary arterial hypertension (PAH).